These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9188882)

  • 21. Dominant lesional T cell receptor rearrangements persist in relapsing psoriasis but are absent from nonlesional skin: evidence for a stable antigen-specific pathogenic T cell response in psoriasis vulgaris.
    Vollmer S; Menssen A; Prinz JC
    J Invest Dermatol; 2001 Nov; 117(5):1296-301. PubMed ID: 11710947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mesenchymal stem cell profile in psoriasis.
    Orciani M; Campanati A; Salvolini E; Lucarini G; Di Benedetto G; Offidani A; Di Primio R
    Br J Dermatol; 2011 Sep; 165(3):585-92. PubMed ID: 21623755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.
    Yazici AC; Karabulut AA; Ozen O; Ekşioğlu M; Ustün H
    J Dermatol; 2007 Jun; 34(6):367-74. PubMed ID: 17535401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermal injection of immunocytes induces psoriasis.
    Wrone-Smith T; Nickoloff BJ
    J Clin Invest; 1996 Oct; 98(8):1878-87. PubMed ID: 8878440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis and Staphylococcus aureus skin colonization in Moroccan patients.
    Elfatoiki FZ; El Azhari M; El Kettani A; Serhier Z; Othmani MB; Timinouni M; Benchikhi H; Chiheb S; Fellah H
    Pan Afr Med J; 2016; 23():33. PubMed ID: 27200138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.
    Bonifati C; Carducci M; Mussi A; D'auria L; Ameglio F
    J Biol Regul Homeost Agents; 1997; 11(4):133-6. PubMed ID: 9582612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study.
    Kleinpenning MM; Smits T; Ewalds E; van Erp PE; van de Kerkhof PC; Gerritsen MJ
    Br J Dermatol; 2006 Sep; 155(3):539-45. PubMed ID: 16911278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of surface topography analysis in psoriatic skin.
    Monti M; Bozzetti M; Motta S; Barbareschi M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():81-3. PubMed ID: 2609892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR; Quist J; Birkenmaier J; Stauch T; Gollnick HP
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperproliferation of normally quiescent keratinocytes in non-lesional psoriatic skin due to high calcium concentration (an organotypic culture model).
    Szabó AK; Bos JD; Das PK
    Acta Microbiol Immunol Hung; 2002; 49(1):129-40. PubMed ID: 12073819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis.
    Mommers JM; van Rossum MM; van Erp PE; van De Kerkhof PC
    Dermatology; 2000; 201(1):15-20. PubMed ID: 10971053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methotrexate, but not narrowband ultraviolet B radiation, suppresses interleukin-33 mRNA levels in psoriatic plaques and protein levels in serum of patients with psoriasis.
    Meephansan J; Subpayasarn U; Ponnikorn S; Chakkavittumrong P; Juntongjin P; Komine M; Ohtsuki M; Poovorawan Y
    J Dermatol; 2018 Mar; 45(3):322-325. PubMed ID: 28836690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.
    Peternel S; Prpić-Massari L; Manestar-Blažić T; Brajac I; Kaštelan M
    Arch Dermatol Res; 2011 Aug; 303(6):389-97. PubMed ID: 21279373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.
    Gilliet M; Conrad C; Geiges M; Cozzio A; Thürlimann W; Burg G; Nestle FO; Dummer R
    Arch Dermatol; 2004 Dec; 140(12):1490-5. PubMed ID: 15611427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analysis of select pathogenic messages in lesional and non-lesional psoriatic skin using non-invasive tape harvesting.
    Benson NR; Papenfuss J; Wong R; Motaal A; Tran V; Panko J; Krueger GG
    J Invest Dermatol; 2006 Oct; 126(10):2234-41. PubMed ID: 16741508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris.
    Alessandrini F; Pfister S; Kremmer E; Gerber JK; Ring J; Behrendt H
    J Invest Dermatol; 2004 Dec; 123(6):1030-6. PubMed ID: 15610510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
    Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
    Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
    Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.